Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Healthstream (HSTM) EBIAT (2016 - 2026)

Healthstream has reported EBIAT over the past 16 years, most recently at $2.5 million for Q4 2025.

  • Quarterly EBIAT fell 48.17% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Dec 2025, down 8.34% year-over-year, with the annual reading at $18.3 million for FY2025, 8.32% down from the prior year.
  • EBIAT was $2.5 million for Q4 2025 at Healthstream, down from $6.1 million in the prior quarter.
  • Over five years, EBIAT peaked at $6.1 million in Q3 2025 and troughed at -$387000.0 in Q4 2021.
  • The 5-year median for EBIAT is $3.8 million (2022), against an average of $3.6 million.
  • Year-over-year, EBIAT crashed 141.93% in 2021 and then surged 732.82% in 2022.
  • A 5-year view of EBIAT shows it stood at -$387000.0 in 2021, then surged by 732.82% to $2.4 million in 2022, then soared by 87.42% to $4.6 million in 2023, then rose by 6.51% to $4.9 million in 2024, then tumbled by 48.17% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's EBIAT are $2.5 million (Q4 2025), $6.1 million (Q3 2025), and $5.4 million (Q2 2025).